Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel, Carboplatin, Amifostine and 3D-CHRT in Stage II-IIIB NSCLC
NCT00004253Phase 2Unknown
- Sponsor
- Baptist Health South Florida
- Start
- Mar 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin, amifostine in non-small cell lung cancer (NSCLC), sponsored by Baptist Health South Florida. Status: unknown.
02
Drugs
paclitaxelcarboplatinamifostine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00004253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004253.